149 related articles for article (PubMed ID: 2465864)
21. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
[No Abstract] [Full Text] [Related]
22. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
[TBL] [Abstract][Full Text] [Related]
24. [Prostatic specific antigen in the serum in prostatic cancer].
Fuse H; Akakura K; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1987 Jul; 33(7):1049-53. PubMed ID: 2446484
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry in the diagnosis of difficult cases of prostatic cancer.
Caillaud JM; Mathieu MC; Carlu C
Prog Clin Biol Res; 1987; 243A():477-83. PubMed ID: 2443919
[No Abstract] [Full Text] [Related]
26. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
27. PSA and PAP as immunohistochemical markers in prostate cancer.
Epstein JI
Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
[TBL] [Abstract][Full Text] [Related]
28. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
[TBL] [Abstract][Full Text] [Related]
29. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
Lange PH; Brawer MK
Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
[No Abstract] [Full Text] [Related]
30. Screening for adenocarcinoma of the prostate.
Miles BJ
Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
[No Abstract] [Full Text] [Related]
31. Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
Kiran PR
Aust Fam Physician; 2001 May; 30(5):458-60. PubMed ID: 11432019
[TBL] [Abstract][Full Text] [Related]
32. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
Bruce AW; Mahan DE; Belville WD
Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
[TBL] [Abstract][Full Text] [Related]
33. Immunohistological localization of prostatic acid phosphatase.
Ablin RJ
Allergol Immunopathol (Madr); 1979; 7(5):361-4. PubMed ID: 395841
[TBL] [Abstract][Full Text] [Related]
34. A radioimmunoassay for prostatic acid phosphatase.
Cooper JF; Foti AG
Natl Cancer Inst Monogr; 1978 Dec; (49):235-7. PubMed ID: 748776
[TBL] [Abstract][Full Text] [Related]
35. UPM3: review of a new molecular diagnostic urine test for prostate cancer.
Saad F
Can J Urol; 2005 Feb; 12 Suppl 1():40-3; discussion 99-100. PubMed ID: 15780164
[TBL] [Abstract][Full Text] [Related]
36. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
37. Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
Wang TY; Kawaguchi TP
Ann Clin Lab Sci; 1986; 16(6):461-6. PubMed ID: 3800301
[TBL] [Abstract][Full Text] [Related]
38. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
39. [Prostate-specific antigen (PSA): diagnostic and prognostic implications in the evaluation of carcinoma of the prostate].
Lo Cigno M; Montanari F; Bercovich E; Soli M; Emili E; Dal Pozzo C; Platè L; Bianchi D
Arch Ital Urol Nefrol Androl; 1989 Mar; 61(1):29-36. PubMed ID: 2469127
[TBL] [Abstract][Full Text] [Related]
40. Economics of screening for carcinoma of the prostate.
Optenberg SA; Thompson IM
Urol Clin North Am; 1990 Nov; 17(4):719-37. PubMed ID: 1699340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
